Inhibition of dengue virus polymerase by blocking of the RNA tunnel

Pornwaratt Niyomrattanakit, Yen Liang Chen, Hongping Dong, Zheng Yin, Min Qing, J. Frasier Glickman, Kai Lin, Dieter Mueller, Hans Voshol, Joanne Y H Lim, Shahul Nilar, Thomas H. Keller, Pei-Yong Shi

Research output: Contribution to journalArticle

71 Citations (Scopus)

Abstract

Dengue virus (DENV) is the most prevalent mosquito-borne viral pathogen in humans. Neither vaccine nor antiviral therapy is currently available for DENV. We report here that N-sulfonylanthranilic acid derivatives are allosteric inhibitors of DENV RNA-dependent RNA polymerase (RdRp). The inhibitor was identified through high-throughput screening of one million compounds using a primer extension-based RdRp assay [substrate poly(C)/oligo(G)20]. Chemical modification of the initial "hit" improved the compound potency to an IC50 (that is, a concentration that inhibits 50% RdRp activity) of 0.7 μM. In addition to suppressing the primer extension-based RNA elongation, the compound also inhibited de novo RNA synthesis using a DENV subgenomic RNA, but at a lower potency (IC50 of 5 μM). Remarkably, the observed anti-polymerase activity is specific to DENV RdRp; the compound did not inhibit WNV RdRp and exhibited IC50s of >100 μM against hepatitis C virus RdRp and human DNA polymerase α and β. UV cross-linking and mass spectrometric analysis showed that a photoreactive inhibitor could be cross-linked to Met343 within the RdRp domain of DENV NS5. On the crystal structure of DENV RdRp, Met343 is located at the entrance of RNA template tunnel. Biochemical experiments showed that the order of addition of RNA template and inhibitor during the assembly of RdRp reaction affected compound potency. Collectively, the results indicate that the compound inhibits RdRp through blocking the RNA tunnel. This study has provided direct evidence to support the hypothesis that allosteric pockets from flavivirus RdRp could be targeted for antiviral development.

Original languageEnglish (US)
Pages (from-to)5678-5686
Number of pages9
JournalJournal of Virology
Volume84
Issue number11
DOIs
StatePublished - Jun 2010
Externally publishedYes

Fingerprint

RNA-directed RNA polymerase
RNA Replicase
Dengue virus
Dengue Virus
DNA-Directed RNA Polymerases
RNA
Inhibitory Concentration 50
Antiviral Agents
inhibitory concentration 50
Poly C
Flavivirus
Hepatitis C virus
DNA-directed DNA polymerase
DNA-Directed DNA Polymerase
crystal structure
Culicidae
crosslinking
Hepacivirus

ASJC Scopus subject areas

  • Immunology
  • Virology

Cite this

Niyomrattanakit, P., Chen, Y. L., Dong, H., Yin, Z., Qing, M., Glickman, J. F., ... Shi, P-Y. (2010). Inhibition of dengue virus polymerase by blocking of the RNA tunnel. Journal of Virology, 84(11), 5678-5686. https://doi.org/10.1128/JVI.02451-09

Inhibition of dengue virus polymerase by blocking of the RNA tunnel. / Niyomrattanakit, Pornwaratt; Chen, Yen Liang; Dong, Hongping; Yin, Zheng; Qing, Min; Glickman, J. Frasier; Lin, Kai; Mueller, Dieter; Voshol, Hans; Lim, Joanne Y H; Nilar, Shahul; Keller, Thomas H.; Shi, Pei-Yong.

In: Journal of Virology, Vol. 84, No. 11, 06.2010, p. 5678-5686.

Research output: Contribution to journalArticle

Niyomrattanakit, P, Chen, YL, Dong, H, Yin, Z, Qing, M, Glickman, JF, Lin, K, Mueller, D, Voshol, H, Lim, JYH, Nilar, S, Keller, TH & Shi, P-Y 2010, 'Inhibition of dengue virus polymerase by blocking of the RNA tunnel', Journal of Virology, vol. 84, no. 11, pp. 5678-5686. https://doi.org/10.1128/JVI.02451-09
Niyomrattanakit P, Chen YL, Dong H, Yin Z, Qing M, Glickman JF et al. Inhibition of dengue virus polymerase by blocking of the RNA tunnel. Journal of Virology. 2010 Jun;84(11):5678-5686. https://doi.org/10.1128/JVI.02451-09
Niyomrattanakit, Pornwaratt ; Chen, Yen Liang ; Dong, Hongping ; Yin, Zheng ; Qing, Min ; Glickman, J. Frasier ; Lin, Kai ; Mueller, Dieter ; Voshol, Hans ; Lim, Joanne Y H ; Nilar, Shahul ; Keller, Thomas H. ; Shi, Pei-Yong. / Inhibition of dengue virus polymerase by blocking of the RNA tunnel. In: Journal of Virology. 2010 ; Vol. 84, No. 11. pp. 5678-5686.
@article{2055b53550f84340a2459813808a969e,
title = "Inhibition of dengue virus polymerase by blocking of the RNA tunnel",
abstract = "Dengue virus (DENV) is the most prevalent mosquito-borne viral pathogen in humans. Neither vaccine nor antiviral therapy is currently available for DENV. We report here that N-sulfonylanthranilic acid derivatives are allosteric inhibitors of DENV RNA-dependent RNA polymerase (RdRp). The inhibitor was identified through high-throughput screening of one million compounds using a primer extension-based RdRp assay [substrate poly(C)/oligo(G)20]. Chemical modification of the initial {"}hit{"} improved the compound potency to an IC50 (that is, a concentration that inhibits 50{\%} RdRp activity) of 0.7 μM. In addition to suppressing the primer extension-based RNA elongation, the compound also inhibited de novo RNA synthesis using a DENV subgenomic RNA, but at a lower potency (IC50 of 5 μM). Remarkably, the observed anti-polymerase activity is specific to DENV RdRp; the compound did not inhibit WNV RdRp and exhibited IC50s of >100 μM against hepatitis C virus RdRp and human DNA polymerase α and β. UV cross-linking and mass spectrometric analysis showed that a photoreactive inhibitor could be cross-linked to Met343 within the RdRp domain of DENV NS5. On the crystal structure of DENV RdRp, Met343 is located at the entrance of RNA template tunnel. Biochemical experiments showed that the order of addition of RNA template and inhibitor during the assembly of RdRp reaction affected compound potency. Collectively, the results indicate that the compound inhibits RdRp through blocking the RNA tunnel. This study has provided direct evidence to support the hypothesis that allosteric pockets from flavivirus RdRp could be targeted for antiviral development.",
author = "Pornwaratt Niyomrattanakit and Chen, {Yen Liang} and Hongping Dong and Zheng Yin and Min Qing and Glickman, {J. Frasier} and Kai Lin and Dieter Mueller and Hans Voshol and Lim, {Joanne Y H} and Shahul Nilar and Keller, {Thomas H.} and Pei-Yong Shi",
year = "2010",
month = "6",
doi = "10.1128/JVI.02451-09",
language = "English (US)",
volume = "84",
pages = "5678--5686",
journal = "Journal of Virology",
issn = "0022-538X",
publisher = "American Society for Microbiology",
number = "11",

}

TY - JOUR

T1 - Inhibition of dengue virus polymerase by blocking of the RNA tunnel

AU - Niyomrattanakit, Pornwaratt

AU - Chen, Yen Liang

AU - Dong, Hongping

AU - Yin, Zheng

AU - Qing, Min

AU - Glickman, J. Frasier

AU - Lin, Kai

AU - Mueller, Dieter

AU - Voshol, Hans

AU - Lim, Joanne Y H

AU - Nilar, Shahul

AU - Keller, Thomas H.

AU - Shi, Pei-Yong

PY - 2010/6

Y1 - 2010/6

N2 - Dengue virus (DENV) is the most prevalent mosquito-borne viral pathogen in humans. Neither vaccine nor antiviral therapy is currently available for DENV. We report here that N-sulfonylanthranilic acid derivatives are allosteric inhibitors of DENV RNA-dependent RNA polymerase (RdRp). The inhibitor was identified through high-throughput screening of one million compounds using a primer extension-based RdRp assay [substrate poly(C)/oligo(G)20]. Chemical modification of the initial "hit" improved the compound potency to an IC50 (that is, a concentration that inhibits 50% RdRp activity) of 0.7 μM. In addition to suppressing the primer extension-based RNA elongation, the compound also inhibited de novo RNA synthesis using a DENV subgenomic RNA, but at a lower potency (IC50 of 5 μM). Remarkably, the observed anti-polymerase activity is specific to DENV RdRp; the compound did not inhibit WNV RdRp and exhibited IC50s of >100 μM against hepatitis C virus RdRp and human DNA polymerase α and β. UV cross-linking and mass spectrometric analysis showed that a photoreactive inhibitor could be cross-linked to Met343 within the RdRp domain of DENV NS5. On the crystal structure of DENV RdRp, Met343 is located at the entrance of RNA template tunnel. Biochemical experiments showed that the order of addition of RNA template and inhibitor during the assembly of RdRp reaction affected compound potency. Collectively, the results indicate that the compound inhibits RdRp through blocking the RNA tunnel. This study has provided direct evidence to support the hypothesis that allosteric pockets from flavivirus RdRp could be targeted for antiviral development.

AB - Dengue virus (DENV) is the most prevalent mosquito-borne viral pathogen in humans. Neither vaccine nor antiviral therapy is currently available for DENV. We report here that N-sulfonylanthranilic acid derivatives are allosteric inhibitors of DENV RNA-dependent RNA polymerase (RdRp). The inhibitor was identified through high-throughput screening of one million compounds using a primer extension-based RdRp assay [substrate poly(C)/oligo(G)20]. Chemical modification of the initial "hit" improved the compound potency to an IC50 (that is, a concentration that inhibits 50% RdRp activity) of 0.7 μM. In addition to suppressing the primer extension-based RNA elongation, the compound also inhibited de novo RNA synthesis using a DENV subgenomic RNA, but at a lower potency (IC50 of 5 μM). Remarkably, the observed anti-polymerase activity is specific to DENV RdRp; the compound did not inhibit WNV RdRp and exhibited IC50s of >100 μM against hepatitis C virus RdRp and human DNA polymerase α and β. UV cross-linking and mass spectrometric analysis showed that a photoreactive inhibitor could be cross-linked to Met343 within the RdRp domain of DENV NS5. On the crystal structure of DENV RdRp, Met343 is located at the entrance of RNA template tunnel. Biochemical experiments showed that the order of addition of RNA template and inhibitor during the assembly of RdRp reaction affected compound potency. Collectively, the results indicate that the compound inhibits RdRp through blocking the RNA tunnel. This study has provided direct evidence to support the hypothesis that allosteric pockets from flavivirus RdRp could be targeted for antiviral development.

UR - http://www.scopus.com/inward/record.url?scp=77951984630&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77951984630&partnerID=8YFLogxK

U2 - 10.1128/JVI.02451-09

DO - 10.1128/JVI.02451-09

M3 - Article

VL - 84

SP - 5678

EP - 5686

JO - Journal of Virology

JF - Journal of Virology

SN - 0022-538X

IS - 11

ER -